Covered recipient · General Payments record
ROSELLA DAWN JORDAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,123.19
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $582.54 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $327.57 | 23 |
| GlaxoSmithKline, LLC. | $72.31 | 4 |
| Lilly USA, LLC | $66.92 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.75 | 2 |
| Acerta Pharma LLC | $40.43 | 2 |
| Novo Nordisk AS | $15.31 | 1 |
| Exact Sciences Corporation | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.92 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425677 | CMS |
| ABBVIE INC. | $9.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425679 | CMS |
| ABBVIE INC. | $9.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425681 | CMS |
| ABBVIE INC. | $10.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425683 | CMS |
| ABBVIE INC. | $22.18 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425685 | CMS |
| ABBVIE INC. | $24.42 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425687 | CMS |
| ABBVIE INC. | $2.64 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425689 | CMS |
| ABBVIE INC. | $9.93 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425691 | CMS |
| ABBVIE INC. | $3.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425693 | CMS |
| ABBVIE INC. | $8.13 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425695 | CMS |
| ABBVIE INC. | $8.13 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425697 | CMS |
| ABBVIE INC. | $0.37 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425699 | CMS |
| ABBVIE INC. | $16.59 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425701 | CMS |
| ABBVIE INC. | $17.87 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425703 | CMS |
| ABBVIE INC. | $24.30 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425705 | CMS |
| ABBVIE INC. | $15.76 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425707 | CMS |
| ABBVIE INC. | $20.26 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425709 | CMS |
| ABBVIE INC. | $12.41 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425711 | CMS |
| ABBVIE INC. | $26.13 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425713 | CMS |
| ABBVIE INC. | $14.43 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425715 | CMS |
| ABBVIE INC. | $13.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425717 | CMS |
| ABBVIE INC. | $11.74 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425719 | CMS |
| ABBVIE INC. | $20.38 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107425721 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.61 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104330758 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.82 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105295574 | CMS |
| Exact Sciences Corporation | $13.25 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114444367 | CMS |
| GlaxoSmithKline, LLC. | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116543272 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116735130 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116323888 | CMS |
| GlaxoSmithKline, LLC. | $19.74 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116348770 | CMS |
| Lilly USA, LLC | $16.20 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933392 | CMS |
| Lilly USA, LLC | $15.92 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135924498 | CMS |
| Lilly USA, LLC | $17.86 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135954581 | CMS |
| Lilly USA, LLC | $16.94 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933394 | CMS |
| Novartis Pharmaceuticals Corporation | $21.45 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087132498 | CMS |
| Novartis Pharmaceuticals Corporation | $25.30 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087132504 | CMS |
| Novo Nordisk Inc | $15.31 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100465272 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.